Latest Regulatory Approval News

Brazilian Rare Earths Limited has obtained the final regulatory approval to operate its rare earth pilot plant in Brazil’s largest petrochemical complex, setting the stage for pilot operations in mid-2026.

Eclipse Metals is set to launch a diamond drilling program at its Grønnedal Rare Earth Project in Greenland, aiming to expand a substantial rare earth resource. Concurrently, assays reveal promising concentrations of critical minerals rubidium and gallium at Ivigtut, positioning the company strategically within evolving global supply chains.

Ardea Resources’ subsidiary Kalgoorlie Nickel Pty Ltd has formalised a Heritage Agreement with the Marlinyu Ghoorlie Native Title Claimant Group, paving the way for responsible development of the Goongarrie Hub Project in Western Australia.

Cambium Bio has struck a licensing deal with Keke Medtech to commercialise its fibrin biologic in dental applications, unlocking new markets and non-dilutive funding.

Race Oncology has activated its first clinical trial site in Hong Kong for the Phase 1 study of RC220 combined with doxorubicin in advanced solid tumours, marking a significant step in accelerating patient enrolment and broadening clinical data.

Black Rock Mining has locked in A$10 million through a two-tranche placement to institutional and sophisticated investors, with a Share Purchase Plan to follow, aiming to accelerate early construction at its Mahenge Graphite Project.

Latrobe Magnesium has commenced start-up operations at its Hazelwood North Demonstration Plant following EPA licence renewal, overcoming recent weather-related supply setbacks. The company aims to begin magnesium oxide production within the week as it advances toward full commissioning.

Southern Palladium has initiated a comprehensive drilling campaign at its Bengwenyama PGM project, marking a critical step toward completing its Definitive Feasibility Study in early 2026. The program aims to refine metallurgical data and mine design while regulatory approvals edge closer.

First Graphene Limited reveals significant progress in commercialising its PureGRAPH graphene technology, highlighting expanding global partnerships and a robust sales pipeline valued over A$10 million.

My Foodie Box Limited is set to pivot from meal kits to mining by acquiring Australian gold, copper, and rare earth projects, renaming itself Tarrina Resources, and relisting on the ASX with a $5 million capital raise.

Halo Technologies Holdings Ltd has announced a renounceable pro rata rights issue aiming to raise up to $11 million at $0.024 per share, partially underwritten by Lodge Corporate Pty Ltd. The capital raise will support the company’s UK market entry, local growth, and ongoing software development.

Lumos Diagnostics, backed by BARDA, is set to begin a pivotal pediatric clinical study to extend the use of its rapid respiratory infection test, FebriDx, to children aged 2–12 in U.S. CLIA-waived settings, potentially unlocking a $1 billion market.